12 Health Care Stocks Moving In Monday's Pre-Market Session
Elutia Inc ELUT
$0.86
▼ -5.33%
($-0.05)
⚡ High Volume
🗓️ Earnings Next Week
Open
$0.89
Prev Close
$0.91
Day Range
$0.81 – $0.91
52W Range
$0.50 – $2.50
Market Cap
$37.88M
P/E (TTM)
0.76
Beta
0.91
EPS (TTM)
$1.16
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-10-08 |
| Shares Out. | 44,210,000 |
| Website | elutia.com/ ↗ |
| Phone | 13026365400 |
| Employees | 26 |
| Revenue | $3.1M |
| Gross Profit | $1.8M |
| Net Income | -$7.5M |
| Free Cash Flow | -$45.8M |
| Total Assets | $55.2M |
| Total Liabilities | $32.7M |
| Equity | $22.5M |
About Elutia Inc
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Elutia Inc is a publicly traded company under the ticker symbol ELUT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)